Form 4: Recursion Pharmaceuticals Director Zavain Dar Acquires Shares Under Compensation Policy

Director Zavain Dar acquired 2,745 shares of Recursion Pharmaceuticals' Class A Common Stock on April 1, 2025, under the company's Outside Director Compensation Policy.

Summary

• On April 1, 2025, Zavain Dar, a director of Recursion Pharmaceuticals, acquired 2,745 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• Following the transaction, Zavain Dar directly owns 110,877 shares of Recursion Pharmaceuticals.
• The transaction was reported on April 3, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally seen as a positive sign, indicating confidence in the company's future. However, the transaction is part of a pre-existing compensation plan, so it's not necessarily a strong signal.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The Outside Director Compensation Policy aligns director interests with shareholder value.

Future Outlook

The document does not contain any specific forward-looking statements.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their alignment with shareholder interests.

Comparison to Industry Standards

• Director compensation policies vary across the pharmaceutical industry.
• Some companies offer stock options, while others provide restricted stock units or direct stock grants.
• The specifics of Recursion Pharmaceuticals' Outside Director Compensation Policy would need to be compared to those of peer companies like Exscientia, Relay Therapeutics, or Schrödinger to assess its competitiveness.

Key Dates

Keywords

Recursion Pharmaceuticals, Zavain Dar, Director, Share Acquisition, Class A Common Stock, Outside Director Compensation Policy, Beneficial Ownership, Form 4